Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Neilan

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
JAMA Health Forum|May 10, 2024
Projected Life Expectancy for Adolescents With HIV in the USAnne M Neilan, Ogochukwu L Ufio, Isaac Ravi Brenner, et al.
Journal of the American College of Cardiology|July 28, 2018
Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart FailureRaza M Alvi, Anne M Neilan, Noor Tariq, et al.
Transplantation|December 16, 2022
The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected RecipientsAnn E Woolley, Aditya R Gandhi, Michelle L Jones, et al.
Journal of the American Heart Association|October 30, 2018
Incidence, Predictors, and Outcomes of Implantable Cardioverter-Defibrillator Discharge Among People Living With HIVRaza M Alvi, Anne M Neilan, Noor Tariq, et al.
Plos One|August 17, 2023
The association between all-cause mortality and HIV acquisition risk groups in the United States, 2001-2014Fatma M Shebl, Yiqi Qian, Julia H A Foote, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2020
Higher Acuity Resource Utilization With Older Age and Poorer HIV Control in Adolescents and Young Adults in the HIV Research NetworkAnne M Neilan, Frances Lu, Kelly A Gebo, et al.
Journal of the International AIDS Society|March 6, 2024
What does the scale-up of long-acting HIV pre-exposure prophylaxis mean for the global hepatitis B epidemic?Amir M Mohareb, Menan Gérard Kouamé, Marcellin Nouaman, et al.
Journal of the Pediatric Infectious Diseases Society|November 14, 2023
Projecting the Clinical and Economic Impacts of Changes to HIV Care Among Adolescents and Young Adults in the United States: Lessons From the COVID-19 PandemicIsaac Ravi Brenner, Kit N Simpson, Clare F Flanagan, et al.
Journal of the International AIDS Society|October 9, 2020
Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort ConsortiumSophie Desmonde, Anne M Neilan, Beverly Musick, et al.
Journal of the Pediatric Infectious Diseases Society|March 25, 2022
The Clinical and Economic Impact of Measles-Mumps-Rubella Vaccinations to Prevent Measles Importations From US Pediatric Travelers Returning From AbroadAudrey C Bangs, Paul Gastañaduy, Anne M Neilan, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
JAMA Health Forum|May 10, 2024
Projected Life Expectancy for Adolescents With HIV in the USAnne M Neilan, Ogochukwu L Ufio, Isaac Ravi Brenner, et al.
Journal of the American College of Cardiology|July 28, 2018
Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart FailureRaza M Alvi, Anne M Neilan, Noor Tariq, et al.
Transplantation|December 16, 2022
The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected RecipientsAnn E Woolley, Aditya R Gandhi, Michelle L Jones, et al.
Journal of the American Heart Association|October 30, 2018
Incidence, Predictors, and Outcomes of Implantable Cardioverter-Defibrillator Discharge Among People Living With HIVRaza M Alvi, Anne M Neilan, Noor Tariq, et al.
Plos One|August 17, 2023
The association between all-cause mortality and HIV acquisition risk groups in the United States, 2001-2014Fatma M Shebl, Yiqi Qian, Julia H A Foote, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2020
Higher Acuity Resource Utilization With Older Age and Poorer HIV Control in Adolescents and Young Adults in the HIV Research NetworkAnne M Neilan, Frances Lu, Kelly A Gebo, et al.
Journal of the International AIDS Society|March 6, 2024
What does the scale-up of long-acting HIV pre-exposure prophylaxis mean for the global hepatitis B epidemic?Amir M Mohareb, Menan Gérard Kouamé, Marcellin Nouaman, et al.
Journal of the Pediatric Infectious Diseases Society|November 14, 2023
Projecting the Clinical and Economic Impacts of Changes to HIV Care Among Adolescents and Young Adults in the United States: Lessons From the COVID-19 PandemicIsaac Ravi Brenner, Kit N Simpson, Clare F Flanagan, et al.
Journal of the International AIDS Society|October 9, 2020
Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort ConsortiumSophie Desmonde, Anne M Neilan, Beverly Musick, et al.
Journal of the Pediatric Infectious Diseases Society|March 25, 2022
The Clinical and Economic Impact of Measles-Mumps-Rubella Vaccinations to Prevent Measles Importations From US Pediatric Travelers Returning From AbroadAudrey C Bangs, Paul Gastañaduy, Anne M Neilan, et al.
Pageof 7